(EPD) Enterprise Products Partners - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2937921078
Stock:
Total Rating 58
Risk 77
Buy Signal 0.17
| Risk 5d forecast | |
|---|---|
| Volatility | 18.8% |
| Relative Tail Risk | 0.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.66 |
| Alpha | 5.22 |
| Character TTM | |
|---|---|
| Beta | 0.378 |
| Beta Downside | 1.017 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.40% |
| CAGR/Max DD | 1.32 |
EPS (Earnings per Share)
Revenue
Description: EPD Enterprise Products Partners
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. It operates in four segments: NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services. The NGL Pipelines & Services segment offers natural gas processing and related NGL marketing activities. This segment operates natural gas processing facilities located in Colorado, Louisiana, Mississippi, New Mexico, Texas, and Wyoming; NGL pipelines; NGL fractionation facilities; NGL and related product storage facilities; and NGL marine terminals. The Crude Oil Pipelines & Services segment operates crude oil pipelines; and crude oil storage and marine terminals, which include a fleet of approximately 225 tractor-trailer tank trucks that are used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates natural gas pipeline systems to gather, treat, and transport natural gas. It leases underground salt dome natural gas storage facilities in Napoleonville, Louisiana; owns an underground salt dome storage cavern in Wharton County, Texas; and transports, stores, and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation facilities, including propylene fractionation units and propane dehydrogenation facilities, and related marketing activities; butane isomerization complex and related deisobutanizer operations; and octane enhancement, isobutane dehydrogenation, and high purity isobutylene production facilities. It also operates refined products pipelines and terminals; and ethylene export terminals; and provides refined products marketing and marine transportation services. Enterprise Products Partners L.P. was founded in 1968 and is headquartered in Houston, Texas.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 5.80b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -2.32 > 1.0 |
| NWC/Revenue: -3.45% < 20% (prev -0.08%; Δ -3.37% < -1%) |
| CFO/TA 0.08 > 3% & CFO 6.11b > Net Income 5.80b |
| Net Debt (34.37b) to EBITDA (9.92b): 3.46 < 3 |
| Current Ratio: 0.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.19b) vs 12m ago -0.23% < -2% |
| Gross Margin: 13.62% > 18% (prev 0.13%; Δ 1350 % > 0.5%) |
| Asset Turnover: 67.87% > 50% (prev 72.85%; Δ -4.98% > 0%) |
| Interest Coverage Ratio: 5.21 > 6 (EBITDA TTM 9.92b / Interest Expense TTM 1.40b) |
Altman Z''
| A: -0.02 (Total Current Assets 13.24b - Total Current Liabilities 15.05b) / Total Assets 77.82b |
| B: error (Retained Earnings missing) |
| C: 0.09 (EBIT TTM 7.30b / Avg Total Assets 77.50b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 47.77b) |
Beneish M
| DSRI: none (Receivables none/9.24b, Revenue 52.60b/56.22b) |
| GMI: 0.94 (GM 13.62% / 12.85%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.94 (Revenue 52.60b / 56.22b) |
| TATA: -0.00 (NI 5.80b - CFO 6.11b) / TA 77.82b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of EPD shares?
As of February 26, 2026, the stock is trading at USD 35.92 with a total of 2,932,517 shares traded.
Over the past week, the price has changed by -0.53%, over one month by +10.46%, over three months by +12.27% and over the past year by +15.64%.
Over the past week, the price has changed by -0.53%, over one month by +10.46%, over three months by +12.27% and over the past year by +15.64%.
Is EPD a buy, sell or hold?
Enterprise Products Partners has received a consensus analysts rating of 4.16.
Therefore, it is recommended to buy EPD.
- StrongBuy: 9
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EPD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.7 | 2% |
| Analysts Target Price | 36.7 | 2% |
EPD Fundamental Data Overview February 21, 2026
P/E Trailing = 13.6015
P/E Forward = 13.3511
P/S = 1.4894
P/B = 2.7559
P/EG = 2.1473
Revenue TTM = 52.60b USD
EBIT TTM = 7.30b USD
EBITDA TTM = 9.92b USD
Long Term Debt = 31.11b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.56b USD (from shortTermDebt, two quarters ago)
Debt = 34.37b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 34.37b USD (using Total Debt 34.37b, CCE unavailable)
Enterprise Value = 112.71b USD (78.34b + Debt 34.37b - (null CCE))
Interest Coverage Ratio = 5.21 (Ebit TTM 7.30b / Interest Expense TTM 1.40b)
EV/FCF = 62.82x (Enterprise Value 112.71b / FCF TTM 1.79b)
FCF Yield = 1.59% (FCF TTM 1.79b / Enterprise Value 112.71b)
FCF Margin = 3.41% (FCF TTM 1.79b / Revenue TTM 52.60b)
Net Margin = 11.03% (Net Income TTM 5.80b / Revenue TTM 52.60b)
Gross Margin = 13.62% ((Revenue TTM 52.60b - Cost of Revenue TTM 45.43b) / Revenue TTM)
Gross Margin QoQ = 14.51% (prev 13.78%)
Tobins Q-Ratio = 1.45 (Enterprise Value 112.71b / Total Assets 77.82b)
Interest Expense / Debt = 1.09% (Interest Expense 375.0m / Debt 34.37b)
Taxrate = 0.24% (4.00m / 1.66b)
NOPAT = 7.28b (EBIT 7.30b * (1 - 0.24%))
Current Ratio = 0.88 (Total Current Assets 13.24b / Total Current Liabilities 15.05b)
Debt / Equity = 1.18 (Debt 34.37b / totalStockholderEquity, two quarters ago 29.21b)
Debt / EBITDA = 3.46 (Net Debt 34.37b / EBITDA 9.92b)
Debt / FCF = 19.16 (Net Debt 34.37b / FCF TTM 1.79b)
Total Stockholder Equity = 28.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.49% (Net Income 5.80b / Total Assets 77.82b)
RoE = 20.02% (Net Income TTM 5.80b / Total Stockholder Equity 28.98b)
RoCE = 12.15% (EBIT 7.30b / Capital Employed (Equity 28.98b + L.T.Debt 31.11b))
RoIC = 11.80% (NOPAT 7.28b / Invested Capital 61.69b)
WACC = 5.41% (E(78.34b)/V(112.71b) * Re(7.31%) + D(34.37b)/V(112.71b) * Rd(1.09%) * (1-Tc(0.00)))
Discount Rate = 7.31% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.16%
[DCF] Terminal Value 84.77% ; FCFF base≈2.50b ; Y1≈2.17b ; Y5≈1.72b
[DCF] Fair Price = 8.34 (EV 52.40b - Net Debt 34.37b = Equity 18.03b / Shares 2.16b; r=5.90% [WACC]; 5y FCF grow -16.29% → 2.90% )
EPS Correlation: 53.20 | EPS CAGR: 6.75% | SUE: 1.54 | # QB: 1
Revenue Correlation: -15.50 | Revenue CAGR: 1.57% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.68 | Chg7d=+0.007 | Chg30d=+0.007 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=2.76 | Chg7d=-0.087 | Chg30d=-0.102 | Revisions Net=-4 | Growth EPS=+3.1% | Growth Revenue=+0.2%
EPS next Year (2027-12-31): EPS=3.06 | Chg7d=+0.061 | Chg30d=+0.041 | Revisions Net=-1 | Growth EPS=+10.8% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.6% (Discount Rate 7.9% - Earnings Yield 7.4%)
[Growth] Growth Spread = -18.8% (Analyst -18.2% - Implied 0.6%)
P/E Forward = 13.3511
P/S = 1.4894
P/B = 2.7559
P/EG = 2.1473
Revenue TTM = 52.60b USD
EBIT TTM = 7.30b USD
EBITDA TTM = 9.92b USD
Long Term Debt = 31.11b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.56b USD (from shortTermDebt, two quarters ago)
Debt = 34.37b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 34.37b USD (using Total Debt 34.37b, CCE unavailable)
Enterprise Value = 112.71b USD (78.34b + Debt 34.37b - (null CCE))
Interest Coverage Ratio = 5.21 (Ebit TTM 7.30b / Interest Expense TTM 1.40b)
EV/FCF = 62.82x (Enterprise Value 112.71b / FCF TTM 1.79b)
FCF Yield = 1.59% (FCF TTM 1.79b / Enterprise Value 112.71b)
FCF Margin = 3.41% (FCF TTM 1.79b / Revenue TTM 52.60b)
Net Margin = 11.03% (Net Income TTM 5.80b / Revenue TTM 52.60b)
Gross Margin = 13.62% ((Revenue TTM 52.60b - Cost of Revenue TTM 45.43b) / Revenue TTM)
Gross Margin QoQ = 14.51% (prev 13.78%)
Tobins Q-Ratio = 1.45 (Enterprise Value 112.71b / Total Assets 77.82b)
Interest Expense / Debt = 1.09% (Interest Expense 375.0m / Debt 34.37b)
Taxrate = 0.24% (4.00m / 1.66b)
NOPAT = 7.28b (EBIT 7.30b * (1 - 0.24%))
Current Ratio = 0.88 (Total Current Assets 13.24b / Total Current Liabilities 15.05b)
Debt / Equity = 1.18 (Debt 34.37b / totalStockholderEquity, two quarters ago 29.21b)
Debt / EBITDA = 3.46 (Net Debt 34.37b / EBITDA 9.92b)
Debt / FCF = 19.16 (Net Debt 34.37b / FCF TTM 1.79b)
Total Stockholder Equity = 28.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.49% (Net Income 5.80b / Total Assets 77.82b)
RoE = 20.02% (Net Income TTM 5.80b / Total Stockholder Equity 28.98b)
RoCE = 12.15% (EBIT 7.30b / Capital Employed (Equity 28.98b + L.T.Debt 31.11b))
RoIC = 11.80% (NOPAT 7.28b / Invested Capital 61.69b)
WACC = 5.41% (E(78.34b)/V(112.71b) * Re(7.31%) + D(34.37b)/V(112.71b) * Rd(1.09%) * (1-Tc(0.00)))
Discount Rate = 7.31% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.16%
[DCF] Terminal Value 84.77% ; FCFF base≈2.50b ; Y1≈2.17b ; Y5≈1.72b
[DCF] Fair Price = 8.34 (EV 52.40b - Net Debt 34.37b = Equity 18.03b / Shares 2.16b; r=5.90% [WACC]; 5y FCF grow -16.29% → 2.90% )
EPS Correlation: 53.20 | EPS CAGR: 6.75% | SUE: 1.54 | # QB: 1
Revenue Correlation: -15.50 | Revenue CAGR: 1.57% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.68 | Chg7d=+0.007 | Chg30d=+0.007 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=2.76 | Chg7d=-0.087 | Chg30d=-0.102 | Revisions Net=-4 | Growth EPS=+3.1% | Growth Revenue=+0.2%
EPS next Year (2027-12-31): EPS=3.06 | Chg7d=+0.061 | Chg30d=+0.041 | Revisions Net=-1 | Growth EPS=+10.8% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.6% (Discount Rate 7.9% - Earnings Yield 7.4%)
[Growth] Growth Spread = -18.8% (Analyst -18.2% - Implied 0.6%)